Prevail Therapeutics
Why Robinhood?
You can watch PRVL and buy or sell other stocks, ETFs, and their options commission-free!About PRVL
Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases.
PRVL Key Statistics
Stock Snapshot
Prevail Therapeutics(PRVL) stock is priced at $23.00, giving the company a market capitalization of 787.7M. It carries a P/E multiple of -10.03.
On 2026-03-12, Prevail Therapeutics(PRVL) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Prevail Therapeutics(PRVL) stock has reached 0, versus its average volume of 1.19M.
Over the past 52 weeks, Prevail Therapeutics(PRVL) stock has traded between a high of $23.35 and a low of $9.02.
Over the past 52 weeks, Prevail Therapeutics(PRVL) stock has traded between a high of $23.35 and a low of $9.02.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.